Janney Montgomery Scott
ATRS

Janney Montgomery Scott’s Antares Pharma, Inc. ATRS Stock Holding History

Janney Montgomery Scott’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-10,000
Closed -$32K – 1990
2017
Q3 		$32K Hold
10,000
– – ﹤0.01% 1815
2017
Q2 		$32K Hold
10,000
– – ﹤0.01% 1728
2017
Q1 		$28K Hold
10,000
– – ﹤0.01% 1727
2016
Q4 		$23K Hold
10,000
– – ﹤0.01% 1667
2016
Q3 		$17K Buy
+10,000
New +$12.3K ﹤0.01% 1516
2016
Q2 		– Sell
-10,000
Closed -$9K – 1235
2016
Q1 		$9K Buy
+10,000
New +$9.68K ﹤0.01% 1257

Other funds holding ATRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Janney Montgomery Scott's ATRS Position: Q4 2017 in Review

Janney Montgomery Scott sold out of Antares Pharma, Inc. (ATRS) in Q4 2017, closing a stake of 10,000 shares — an estimated $32K sold.

Janney Montgomery Scott first reported a position in ATRS in Q1 2016 and held it in 6 quarters. The position peaked at $32K in Q3 2017. 110 funds tracked by Wall St. Rank hold ATRS as of Q4 2017.

  • Janney Montgomery Scott reported no remaining Antares Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Janney Montgomery Scott sold 10,000 Antares Pharma, Inc. shares in Q4 2017, an estimated $32K.
  • Janney Montgomery Scott first reported a position in Antares Pharma, Inc. in Q1 2016 and held it in 6 quarters.
  • Janney Montgomery Scott's Antares Pharma, Inc. position peaked at $32K in Q3 2017.
  • 110 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q4 2017.

Based on Janney Montgomery Scott's 13F filing for Q4 2017, filed 14 Feb 2018.